Cerezyme IV 400 units, by Sanofi, contains Imiglucerase (genetically recombinant), an enzyme replacement therapy for Type 1 Gaucher disease. This injectable drug is supplied as 400 units 1 bottle (YJ code: 3959406D2021).
Cerezyme IV 400 units
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →